What is NDC 67386-130?

67386-130 is the product NDC for Vyepti (eptinezumab-jjmr), Eptinezumab 100 mg/mL injection, listed with the FDA by Lundbeck Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Lundbeck Pharmaceuticals LLC, NDC labeler code 67386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vyepti?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vyepti NDC 67386-130 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67386-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67386-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67386-130-51	67386013051	1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Feb 21, 2020
67386-130-91	67386013091	1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 1, 2023 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vyepti
Generic name (nonproprietary): eptinezumab-jjmr
Active ingredients: Eptinezumab — 100 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Lundbeck Pharmaceuticals LLCNDC labeler code 67386
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761119
Marketing start: Feb 21, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Calcitonin Gene-related Peptide Antagonists (Mechanism)
Identifiers: Product ID 67386-130_ae1b6705-69c6-4f31-8017-2a3abc032d53SPL ID ae1b6705-69c6-4f31-8017-2a3abc032d53SPL set ID 79065861-6aa5-4d1f-829f-3a6471286b36RxCUI 2283049, 2283054UNII 8202AY8I7HUPC 0367386130517
Pharmacologic class: Calcitonin Gene-related Peptide Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467386013051 followed by a unit qualifier and the quantity

Package 67386-0130-51. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 5, 2026.

Indications (excerpt from the label)

VYEPTI is indicated for the preventive treatment of migraine in adults. VYEPTI is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67386-130

What is NDC 67386-130?: 67386-130 is the product NDC for Vyepti (eptinezumab-jjmr), Eptinezumab 100 mg/mL injection, listed with the FDA by Lundbeck Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vyepti (Eptinezumab-jjmr).
What is the active ingredient?: Eptinezumab.
Who is the labeler?: Lundbeck Pharmaceuticals LLC, NDC labeler code 67386. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vyepti?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Vyepti (Eptinezumab-jjmr) NDC 67386-130